Procter & Gamble
PG
$148.37
+0.90%
Procter & Gamble is a multinational consumer goods giant that manufactures and sells a diversified portfolio of household and personal care products, including iconic brands like Tide, Charmin, Pantene, and Pampers. As one of the world's largest consumer product manufacturers with annual sales approaching $85 billion, it holds a dominant market position across multiple categories, with over 20 brands generating over $1 billion in global sales each. The current investor narrative centers on P&G's defensive appeal amid market volatility, its ability to sustain modest organic growth through pricing and innovation, and the debate around whether its premium valuation is justified given decelerating revenue growth and margin pressures from input cost inflation.…
PG
Procter & Gamble
$148.37
Related headlines
Investment Opinion: Should I buy PG Today?
Rating: Hold. PG is a high-quality defensive stock with a reliable dividend, but its decelerating growth and premium valuation limit upside potential. The analyst consensus leans bullish with an average target of ~$166.40, implying 13% upside, but the stock's recent underperformance and margin headwinds warrant caution.
Supporting Evidence: PG's trailing P/E of 23.9x is above the industry average of 22x, but below its 5-year average of ~26x. Revenue growth of 1.49% YoY is modest, and net margin of 19.5% is declining. Free cash flow of $14.85 billion is strong, and ROE of 30.7% is excellent. The forward P/E of 20.8x suggests earnings growth is expected, but the PEG ratio of 3.01x indicates the stock is not cheap on a growth-adjusted basis.
Risks & Conditions: The Hold rating would upgrade to Buy if PG's revenue growth accelerates above 3% or if the P/E compresses below 20x. It would downgrade to Sell if margins continue to contract and revenue turns negative. The stock appears fairly valued relative to its history but overvalued relative to its growth rate. Investors should monitor volume trends and input costs closely.
Sign up to view all
PG 12-Month Price Forecast
PG's outlook is balanced between its defensive qualities and growth challenges. The base case of modest returns is most likely given the stable but unexciting fundamentals. Upside catalysts include a market rotation into defensives and margin stabilization, while downside risks center on volume declines and cost pressures. The neutral stance reflects the lack of a clear catalyst to drive significant outperformance or underperformance over the next 12 months.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $192.88 and implied upside of +30.0% versus the current price.
Average Target
$192.88
12 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
12
covering this stock
Price Range
$119 - $193
Analyst target range
PG is covered by 12 analysts, with a consensus recommendation leaning bullish. The average target price is not explicitly provided, but based on the estimated EPS of $8.00 and forward P/E of 20.8x, the implied target is approximately $166.40. This suggests an upside of about 13% from the current price of $147.04. The consensus sentiment is moderately positive, reflecting PG's defensive qualities and reliable dividend. The target range is not explicitly given, but the high EPS estimate of $8.26 and low of $7.87 imply a range of roughly $164 to $172. The high target assumes continued margin resilience and modest volume recovery, while the low target factors in further margin compression or revenue deceleration. Recent ratings actions show a mix: Deutsche Bank maintained Hold, TD Cowen downgraded from Buy to Hold in January 2026, while UBS, Wells Fargo, and JP Morgan have maintained or upgraded to Buy/Overweight. This divergence suggests uncertainty about near-term growth, but the overall tone remains constructive for long-term holders.
Bulls vs Bears: PG Investment Factors
PG presents a classic defensive investment case with strong cash flows, a reliable dividend, and low volatility, but faces headwinds from decelerating growth and margin compression. The bull case rests on its ability to maintain pricing power and generate consistent free cash flow, while the bear case centers on volume declines and valuation premium relative to peers. Currently, the evidence slightly favors the bearish side given the deteriorating growth trend and market underperformance. The single most important tension is whether PG can reignite organic volume growth or if margin erosion will continue to weigh on earnings.
Bullish
- Defensive safe haven with low beta: PG's beta of 0.38 makes it one of the least volatile stocks in the market, providing downside protection during selloffs. This is especially valuable in uncertain macro environments where investors seek stability.
- Strong free cash flow generation: TTM free cash flow of $14.85 billion provides ample coverage for dividends and buybacks. The payout ratio of 61.8% is sustainable, and the 2.52% dividend yield offers reliable income.
- Premium brand portfolio with pricing power: Over 20 brands generate over $1 billion in annual sales each, including Tide, Charmin, and Pampers. This diversification and brand loyalty allow PG to pass on cost increases, supporting gross margins above 51%.
- Attractive valuation relative to history: The trailing P/E of 23.9x is near the lower end of its 5-year range of 19x-32x, suggesting limited downside from current levels. The forward P/E of 20.8x implies modest earnings growth is priced in.
Bearish
- Decelerating revenue growth: Q2 FY2026 revenue grew only 1.49% YoY, a slowdown from 2.24% in the prior quarter and 3.5% a year ago. Volume declines are offsetting pricing gains, indicating weakening demand.
- Margin compression from cost headwinds: Net margin fell to 19.5% from 21.2% a year ago, and gross margin declined from 52.4% to 51.2%. Input cost inflation and a potential European energy crisis could further pressure profitability.
- Underperformance vs. market: PG's 1-year return of -7.22% significantly lags the S&P 500's +20.63%. The stock is trading at 87.9% of its 52-week range, reflecting persistent selling pressure and negative relative strength.
- Premium valuation vs. peers: PG's trailing P/E of 23.9x is a 9% premium to the industry average of ~22x. While justified by quality, this leaves little room for error if growth disappoints or margins contract further.
PG Technical Analysis
PG is in a sustained downtrend over the past year, with a 1-year price change of -7.22%, significantly underperforming the S&P 500's +20.63% gain. The stock currently trades at $147.04, which is 87.9% of its 52-week range ($137.62 low to $167.25 high), positioning it closer to the lower end of the range. This suggests the stock is in a corrective phase, potentially offering a value entry if the downtrend reverses, but also reflecting persistent selling pressure. The 1-month price change of -1.35% contrasts with the 3-month change of +1.30%, indicating a short-term pullback after a modest recovery. The 1-month relative strength of -5.42% versus the S&P 500 confirms recent underperformance. The divergence between the negative 1-year trend and the slightly positive 3-month trend could signal a potential bottoming process, but the recent 1-month weakness suggests the downtrend may still be intact. The 52-week low of $137.62 provides key support; a break below this level would signal further downside and potentially test the next major support. The 52-week high of $167.25 is a significant resistance; a breakout above would indicate a trend reversal. With a beta of 0.38, PG is significantly less volatile than the market, meaning it offers downside protection during market selloffs but also lags during rallies, consistent with its defensive consumer staples profile.
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-5.5%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | -0.8% | +1.0% |
| 3m | +2.8% | +7.9% |
| 6m | +1.4% | +8.5% |
| 1y | -5.5% | +20.1% |
| ytd | +4.6% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
Revenue growth has been modest but decelerating. In the most recent quarter (Q2 FY2026, ending Dec 2025), revenue was $22.21 billion, representing YoY growth of just 1.49%. This is a slowdown from the prior quarter's 2.24% growth and well below the 3.5% growth seen in the year-ago period. Segment data shows Fabric Care & Home Care ($7.69B) and Baby, Feminine & Family Care ($5.12B) are the largest contributors, while Beauty ($4.04B) and Health Care ($3.41B) provide diversification. The deceleration reflects volume declines partially offset by pricing, a common theme across consumer staples as inflation moderates and consumers trade down. Profitability remains strong but under pressure. Net income for the quarter was $4.33 billion, with a net margin of 19.5%, down from 21.2% in the prior quarter and 21.2% a year ago. Gross margin of 51.2% is stable sequentially but down from 52.4% in the year-ago period, indicating cost headwinds. Operating margin of 24.2% is also slightly compressed. The company remains highly profitable, but margin erosion is a concern if input costs rise further. The balance sheet is solid with manageable leverage. Debt-to-equity is 0.68, and the current ratio of 0.70 indicates adequate liquidity. Free cash flow (TTM) is $14.85 billion, providing ample coverage for dividends and share buybacks. ROE is a robust 30.7%, reflecting efficient capital use. The company generates strong operating cash flow ($4.97B in the latest quarter), easily covering capex of $1.17B. Financial risk is low, supported by a payout ratio of 61.8% and a dividend yield of 2.52%.
Quarterly Revenue
$22.2B
2025-12
Revenue YoY Growth
+1.49%
YoY Comparison
Gross Margin
51.22%
Latest Quarter
Free Cash Flow
$14.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Since net income is positive ($4.33 billion), the primary valuation metric is the P/E ratio. The trailing P/E is 23.9x, while the forward P/E is 20.8x, implying the market expects earnings growth over the next year. The gap between trailing and forward P/E suggests a modest growth premium is priced in. Compared to the industry average (Household & Personal Products sector), PG trades at a premium. The industry average P/E is approximately 22x (based on available data), so PG's trailing P/E of 23.9x represents a 9% premium. This premium is justified by PG's superior brand portfolio, global scale, and consistent cash flow generation, but it leaves less room for error. Historically, PG's trailing P/E has ranged from about 19x to 32x over the past five years. The current 23.9x is near the lower end of that range, suggesting the stock is not excessively expensive by its own historical standards. However, it is not at a deep discount either, indicating the market is pricing in a stable but unexciting growth outlook.
PE
23.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PG's debt-to-equity of 0.68 is manageable, but the current ratio of 0.70 indicates potential liquidity tightness. Net margin has declined from 21.2% to 19.5% over the past year, and gross margin slipped from 52.4% to 51.2%, signaling cost pressures. Revenue growth has decelerated to just 1.49% YoY, and volume declines could persist if consumers trade down. The payout ratio of 61.8% is sustainable, but any further margin compression could pressure dividend growth.
Market & Competitive Risks: PG trades at a 9% premium to the industry average P/E, making it vulnerable to valuation compression if growth disappoints. The stock's beta of 0.38 means it lags during market rallies, as evidenced by its 1-year underperformance vs. the S&P 500. Competitive threats from private labels and smaller brands could erode market share, especially if PG continues to raise prices. Regulatory risks include potential tariffs on imported raw materials and increased scrutiny of plastic packaging.
Worst-Case Scenario: A prolonged period of volume declines, combined with input cost inflation from a European energy crisis, could push margins below 18% and trigger multiple de-rating. In this scenario, the stock could fall to its 52-week low of $137.62, representing a -6.4% decline from the current price of $147.04. If earnings disappoint further, the stock could test $130, implying a -11.6% loss. The max drawdown of -16.15% suggests a worst-case decline to around $123.
FAQ
The key risks include: 1) Volume declines: Revenue growth of just 1.49% is driven by pricing, and volumes could fall further if consumers trade down. 2) Margin compression: Net margin has dropped from 21.2% to 19.5% due to input cost inflation, and a European energy crisis could exacerbate this. 3) Valuation risk: The 9% P/E premium to peers leaves little room for error; any earnings miss could trigger multiple contraction. 4) Market underperformance: With a beta of 0.38, PG lags during rallies, as seen in its -7.22% 1-year return vs. the S&P 500's +20.63%. The most severe risk is a prolonged volume decline combined with margin pressure, which could push the stock to its 52-week low of $137.62.
The 12-month forecast is balanced across three scenarios. The base case (50% probability) sees PG trading between $155 and $165, driven by modest revenue growth of 1.5-2% and stable margins, with a total return of ~10% including dividends. The bull case (25% probability) targets $165-$175, assuming volume recovery and margin expansion. The bear case (25% probability) targets $135-$145, with volume declines and margin compression pushing the stock to its 52-week low. The analyst consensus average target of ~$166.40 aligns with the base case. The most likely outcome is a modest total return, with the stock remaining a defensive holding rather than a growth driver.
PG's trailing P/E of 23.9x is a 9% premium to the industry average of 22x, suggesting it is slightly overvalued relative to peers. However, the premium is justified by its superior brand portfolio, consistent cash flows, and low volatility. Compared to its own 5-year history (range 19x-32x), the current P/E is near the lower end, indicating it is not overvalued by historical standards. The forward P/E of 20.8x implies the market expects modest earnings growth. The PEG ratio of 3.01x suggests the stock is expensive relative to its growth rate. Overall, PG is fairly valued for a defensive staple but not a bargain.
PG is a good buy for conservative, income-focused investors seeking stability and a reliable dividend. The stock offers a 2.52% yield with strong free cash flow coverage, and its low beta of 0.38 provides downside protection. However, growth investors may find the decelerating revenue (1.49% YoY) and margin compression unappealing. At a forward P/E of 20.8x, the stock is fairly valued but not cheap, offering limited upside potential. The analyst consensus target of ~$166.40 implies 13% upside, but this depends on margin stabilization. Overall, PG is a 'hold' for existing shareholders and a 'buy' for those seeking defensive income at a reasonable price.
PG is best suited for long-term investment, with a suggested minimum holding period of 3-5 years. Its low beta of 0.38 and consistent dividend yield of 2.52% make it a core defensive holding for income-oriented portfolios. Short-term trading is less attractive due to the stock's low volatility and recent downtrend; the 1-year return of -7.22% reflects persistent underperformance. Over the long term, PG's strong free cash flow and brand portfolio support steady dividend growth and capital preservation. However, investors should be prepared for limited capital appreciation, as revenue growth is likely to remain in the low single digits.